Intractable Epilepsy
13
3
3
3
Key Insights
Highlights
Success Rate
60% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
15.4%
2 terminated out of 13 trials
60.0%
-26.5% vs benchmark
15%
2 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (13)
Characterization and Analysis of Evoked Cortical Responses in Participants With Medication-intractable Epilepsy
Diffusion Tensor and Functional Connectivity Imaging in Pediatric Epilepsy: Imaging/Histology Correlation
Evaluation of Keyo in Children With Epilepsy
Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy
Biomarker for Creatine Deficiency Syndromes (BioCDS)
Long-term Cardiac Monitoring in Epilepsy
Network Effects of Therapeutic Deep Brain Stimulation
Novel Network Analysis of Intracranial Stereoelectroencephalography
EXPRESON-IN : Intracerebral Recordings of P3a Responses to Expressive Own-names
Safety of Using NaviFUS System in Patients With Drug Resistant Epilepsy
Pilot Trial to Evaluate The Effect of Oral Methylprednisolone on Seizure Frequency in Children With Epilepsy
Ketogenic Diet Drink Study
The Impact of Reducing Overtreatment on Quality of Life in Children With Refractory Epilepsy